MACD Bullish Stocks — Financial View · Services-Commercial Physical & Biological Research
6 stocks match the MACD Bullish Stocks screen. Stocks whose MACD line is above its signal line — a bullish momentum state, largest first. Financial columns. Filtered to Services-Commercial Physical & Biological Research. Data as of close · Checked
| INCY | Incyte | $24.0B | — | 5.5% | 7.1% | 1.6% | 3.84 | 3.38 | 92.7% | 10.4% | 6.7% | 117.98 | -4.02% | 76K |
| NRC | Nrc Health | $541M | 2.2% | 8.3% | — | — | 0.64 | — | — | 11.1% | 8.4% | 25.47 | -5.75% | 9K |
| ONMD | OneMedNet Corp | $26M | — | — | — | — | 0.28 | — | -68.8% | — | — | 4.33 | -5.25% | 405 |
| ISPC | iSpecimen Inc. | $2M | — | — | — | — | 0.82 | 1.98 | — | — | — | 0.81 | -3.56% | 1K |
| BIAF | bioAffinity Technologies, Inc. | $1M | — | — | — | — | 1.44 | 1.02 | — | — | — | 2.65 | -12.42% | 479 |
| ICLR | Icon Plc | — | — | 2.8% | 4.9% | 3.6% | 1.32 | 0.37 | — | 8.7% | 5.4% | 201.81 | -0.60% | 127K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.